Biohm is a Cleveland, OH-based microbiome company that leverages microbiome data to create products and ingredients intended to improve individual health. Its product lineup includes the BIOHM FX probiotic supplement designed to reduce digestive plaque, additional probiotic and prebiotic supplements, and a personalized Gut Test. The company raised $7.5M in equity financing to support growth. Biohm plans to use the funds to fast-track development of A.I. technology and targeted, data-driven microbiome formulations. The company is led by CEO Afif Ghannoum and President Sam Schatz. Biohm Health is a microbiome company that applies a proprietary dual-action technology to neutralize harmful bacteria and fungi and deliver a probiotic designed to break down digestive plaque while maintaining overall microbiome balance. The company sells probiotics and other gut-health products and offers The BIOHM Gut Report, a test that identifies and measures gut bacteria and fungi and provides personalized, actionable wellness recommendations including nutritional advice. The business is led by CEO Afif Ghannoum and was founded by Afif Ghannoum and Dr. Mahmoud Ghannoum following their discovery that bad bacteria and bad fungus collaborate to create digestive imbalance. Biohm is based in Cleveland, OH. In December 2017 the company raised funding from Vanterra Capital; the terms of the investment were not disclosed. As part of the deal, Vanterra will join BIOHM's board alongside the founders.

Total raised

$8M

Funding rounds

2

Latest round

Equity

Latest activity

Jan 2023